CSPI Applauds IOM Recommendations to Strengthen Standards for Health-related Claims for Foods and Dietary Supplements

Statement of CSPI Legal Affairs Director Bruce Silverglade

May 12, 2010

The Institute of Medicine report gives the Food and Drug Administration a basis to establish a regulatory framework for health-related claims on foods and dietary supplements labels. While the FDA has recently begun a case-by-case crackdown on misleading food labeling claims, the agency lacks a comprehensive regulatory framework for many types of labeling claims. Misleading health-related claims on food labels are an industry-wide problem and need an industry-wide solution.

We support the IOM conclusion that when foods or dietary supplements claim to provide drug-like benefits, they should be held to rigorous scientific standards. Right now, FDA policies are riddled with loopholes that let companies make phony promises on weak scientific evidence.

CSPI petitioned the FDA in 2002 to establish a comprehensive regulatory framework for foods with added ingredients that claim special health benefits. The IOM report now gives the agency a firm scientific basis to act.

Right now the supermarket is a jungle of unsupported health-related claims. We hope that the IOM report will provide the basis for fundamental change of how food labeling claims are regulated.


Get Updates Via Email

Journalists can receive CSPI news releases via email.
Not a journalist?

Sign Up for Email Now



Subscribe Now

Subscribe Now »

Subscribe Today and Save!

In Recent Issues

Cover Story: 1 in 8: What You May Not Know About Breast Cancer

Special Feature: Soy Oh Soy: Is It Really Bad For You?

Brand-Name Rating: Pasta Sauce

Subscribe Now

Request permission to reuse content

The use of information from this site for commercial purposes is strictly prohibited without written permission from CSPI.